Enzon Pharmaceuticals, Inc. is a pharmaceutical company. Based on the filing's limited business description text provided, the company operates as Enzon Pharmaceuticals, Inc. with subsidiaries. The filing references forward-looking statements and standard SEC disclosure items, but the actual Item 1 business description content detailing specific products or services is not included in the provided text excerpt.
Q2 FY2026 — expected 2026-09-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001104659-26-022313 | EDGAR | 22K words |
| 2025-02-21 | 2024-12-31 | 0001410578-25-000177 | EDGAR | — |
| 2024-03-20 | 2023-12-31 | 0001410578-24-000245 | EDGAR | — |
| 2023-02-16 | 2022-12-31 | 0001410578-23-000136 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0001410578-22-000226 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001104659-21-026712 | EDGAR | — |
| 2020-02-19 | 2019-12-31 | 0001104659-20-022802 | EDGAR | — |
| 2019-02-21 | 2018-12-31 | 0001144204-19-009301 | EDGAR | — |
| 2018-03-21 | 2017-12-31 | 0001144204-18-016199 | EDGAR | — |
| 2017-03-24 | 2016-12-31 | 0001144204-17-016511 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001104659-25-110410 | EDGAR | 16K words |
| 2025-08-14 | 2025-06-30 | 0001410578-25-001810 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001410578-25-001164 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001410578-24-001747 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001410578-24-001220 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001410578-24-000735 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001410578-23-002306 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001410578-23-001577 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001410578-23-000888 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001410578-22-003068 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001410578-22-002040 | EDGAR | — |
| 2022-04-26 | 2022-03-31 | 0001410578-22-001018 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-035301 | EDGAR | 2K words |
| 2026-03-25 | 0001104659-26-034187 | EDGAR | — |
| 2026-03-24 | 0001104659-26-033624 | EDGAR | — |
| 2026-03-19 | 0001104659-26-032092 | EDGAR | — |
| 2026-03-18 | 0001104659-26-029952 | EDGAR | — |
| 2026-03-16 | 0001104659-26-028449 | EDGAR | — |
| 2026-03-11 | 0001104659-26-026169 | EDGAR | — |
| 2026-03-09 | 0001104659-26-025217 | EDGAR | — |
| 2026-02-27 | 0001104659-26-021051 | EDGAR | — |
| 2026-02-11 | 0001104659-26-013506 | EDGAR | — |
339 total filings indexed. 307 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000727510 |
| Ticker | ENZN |
| Exchange | OTC |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report